Haw Par (SGX:H02) - Prezzo delle azioni, notizie e analisi

H02 Panoramica delle azioni

H02 analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	5/6
Salute finanziaria	5/6
Dividendi	3/6

Premi

Il rapporto prezzo/utile ( 10.6 x) è inferiore al mercato SG ( 11.7 x)

Gli utili sono cresciuti del 33.8% nell'ultimo anno

Analisi del rischio

Il dividendo di 3.56% non è ben coperto dai flussi di cassa liberi

Haw Par Corporation Limited Concorrenti

Hyphens Pharma International

Catalist:1J5

S$89.6m

AstraZeneca Pharma India

BSE:506820

₹161.6b

Harmony Biosciences Holdings

NasdaqGM:HRMY

US$2.0b

Shenyang Xingqi PharmaceuticalLtd

SZSE:300573

CN¥14.3b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Haw Par
Prezzi storici delle azioni
Prezzo attuale dell'azione	S$11.24
Massimo di 52 settimane	S$11.35
Minimo di 52 settimane	S$9.44
Beta	0.37
1Variazione di 1 mese	3.40%
Variazione a 3 mesi	11.51%
Variazione di 1 anno	14.58%
3Variazione a 3 anni	-0.089%
Variazione a 5 anni	-16.18%
Variazione dall'IPO	429.20%

Notizie e aggiornamenti recenti

Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

Sep 08

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Apr 25

Recent updates

Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

Sep 08

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Apr 25

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Haw Par Corporation Limited's (SGX:H02) CEO For Now

Apr 16

Should Haw Par Corporation Limited (SGX:H02) Be Part Of Your Dividend Portfolio?

Jan 03

Haw Par Corporation Limited (SGX:H02) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Dec 13

Shareholders Of Haw Par (SGX:H02) Must Be Happy With Their 50% Return

Nov 23

Rendimenti per gli azionisti

	H02	SG Pharmaceuticals	SG Mercato
7D	0.4%	-0.2%	-1.1%
1Y	14.6%	5.7%	14.7%

Ritorno vs Industria: H02 ha superato il SG Pharmaceuticals che ha restituito 5.7 % nell'ultimo anno.

Rendimento vs Mercato: H02 ha eguagliato il mercato SG che ha restituito 14.7 % nell'ultimo anno.

Volatilità dei prezzi

Is H02's price volatile compared to industry and market?
H02 volatility
H02 Average Weekly Movement	1.7%
Pharmaceuticals Industry Average Movement	6.1%
Market Average Movement	4.4%
10% most volatile stocks in SG Market	14.7%
10% least volatile stocks in SG Market	2.2%

Prezzo delle azioni stabile: H02 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 2% ) di H02 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1969	n/a	Ee Lim Wee	www.hawpar.com

Haw Par Corporation Limited, insieme alle sue consociate, produce, commercializza e commercia prodotti sanitari a Singapore, nei Paesi ASEAN, in altri Paesi asiatici e a livello internazionale. La società opera attraverso tre segmenti: Sanità, Investimenti e Altri. L'azienda produce e distribuisce prodotti analgesici topici con i marchi Tiger Balm e Kwan Loong e investe in titoli quotati.

Haw Par Corporation Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Haw Par con la sua capitalizzazione di mercato?
H02 statistiche fondamentali
Capitalizzazione di mercato	S$2.49b
Guadagni(TTM)	S$234.43m
Ricavi(TTM)	S$239.06m

10.6x

Rapporto P/E

10.4x

Rapporto P/S

H02 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
H02 Conto economico (TTM)
Ricavi	S$239.06m
Costo del fatturato	S$102.66m
Profitto lordo	S$136.40m
Altre spese	-S$98.03m
Guadagni	S$234.43m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	1.06
Margine lordo	57.06%
Margine di profitto netto	98.06%
Rapporto debito/patrimonio netto	1.0%

Come si è comportato H02 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

3.6%

Rendimento attuale del dividendo

38%

Rapporto di remunerazione

H02 Panoramica delle azioni

Premi

Analisi del rischio

Haw Par Corporation Limited Concorrenti

Catalist:1J5

S$89.6m

BSE:506820

₹161.6b

NasdaqGM:HRMY

US$2.0b

SZSE:300573

CN¥14.3b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

First half 2024 earnings released: EPS: S$0.55 (vs S$0.47 in 1H 2023)

First half dividend of S$0.20 announced

Haw Par Corporation Limited to Report First Half, 2024 Results on Aug 14, 2024

Haw Par Corporation Limited Approves Second & Final Tax-Exempt Dividend for the Financial Year Ended 31 December 2023

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Recent updates

Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks

First half 2024 earnings released: EPS: S$0.55 (vs S$0.47 in 1H 2023)

First half dividend of S$0.20 announced

Haw Par Corporation Limited to Report First Half, 2024 Results on Aug 14, 2024

Haw Par Corporation Limited Approves Second & Final Tax-Exempt Dividend for the Financial Year Ended 31 December 2023

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Haw Par Corporation Limited Announces Board Appointments

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Haw Par Corporation Limited's (SGX:H02) CEO For Now

Full year 2023 earnings released: EPS: S$0.98 (vs S$0.67 in FY 2022)

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20

Haw Par Corporation Limited, Annual General Meeting, Apr 23, 2024

Haw Par Corporation Limited Announces Retirement of Gn Hiang Meng as Non-Executive and Independent Director

Full year 2023 earnings released: EPS: S$0.98 (vs S$0.67 in FY 2022)

Haw Par Corporation Limited to Report Fiscal Year 2023 Results on Feb 26, 2024

Haw Par (SGX:H02) Is Increasing Its Dividend To SGD0.20

First half 2023 earnings released: EPS: S$0.47 (vs S$0.35 in 1H 2022)

Haw Par Corporation Limited Declares First and Interim One-Tier Tax Exempt Dividend for the Financial Year Ending 31 December 2023, Payable on 7 September 2023

Haw Par Corporation Limited to Report First Half, 2023 Results on Aug 11, 2023

Insufficient new directors

Haw Par (SGX:H02) Could Easily Take On More Debt

Haw Par Corporation Limited Approves Second and Final Tax-Exempt Dividend for the Financial Year Ended December 31, 2022

Upcoming dividend of S$0.15 per share at 3.1% yield

Full year 2022 earnings released: EPS: S$0.67 (vs S$0.50 in FY 2021)

Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.15

Full year 2022 earnings released: EPS: S$0.67 (vs S$0.50 in FY 2021)

Haw Par (SGX:H02) Has A Rock Solid Balance Sheet

Haw Par (SGX:H02) Will Pay A Dividend Of SGD0.15

Haw Par Corporation Limited Announces First Interim Cash Dividend, Payable on 2 September 2022

First half 2022 earnings released

Haw Par Corporation Limited Announces Appointment of Chiew Kun Long, Alvin as Company Secretary

Upcoming dividend of S$0.15 per share

Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15

Haw Par Corporation Limited Approves to Declare One-Tier Tax-Exempt Second & Final Dividend for Fiscal Year 2021

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Haw Par (SGX:H02) Is Due To Pay A Dividend Of S$0.15

Haw Par Corporation Limited, Annual General Meeting, Apr 27, 2022

Haw Par (SGX:H02) Has Affirmed Its Dividend Of S$0.15

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Haw Par Corporation Limited Appoints Chow Say Suan to Member of Investment Committee

Haw Par Corporation Limited to Report Fiscal Year 2021 Results on Feb 25, 2022

Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15

Upcoming dividend of S$0.15 per share

Haw Par Corporation Limited Announces Second & Final Tax Exempt Dividend for the Financial Year Ended December 31, 2020

Non-Executive Independent Director has left the company

Non-Executive Independent Director has left the company

Upcoming dividend of S$0.15 per share

Full year 2020 earnings released: EPS S$0.54 (vs S$0.82 in FY 2019)

Peter Sim Swee Yam Intends to Retire as Non-Executive and Independent Director of Haw Par Corporation Limited

Full year 2020 earnings released

New 90-day high: S$12.18

Haw Par Corporation Limited to Report Fiscal Year 2020 Results on Feb 22, 2021

New 90-day high: S$11.62

Is Haw Par Corporation Limited (SGX:H02) Popular Amongst Institutions?

New 90-day high: S$11.06

Should Haw Par Corporation Limited (SGX:H02) Be Part Of Your Dividend Portfolio?

New 90-day high: S$10.65

Haw Par Corporation Limited (SGX:H02) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Shareholders Of Haw Par (SGX:H02) Must Be Happy With Their 50% Return

New 90-day high: S$9.81